936 TOOKAD ® SOLUBLE (PADELIPORFIN) SECOND GENERATION VASCULAR TARGETED PHOTODYNAMIC THERAPY (VTP) FOR PROSTATE CANCER: SAFETY AND FEASIBILITY

Authors :: Caroline M. Moore
Luc Cormier
A. Villers
Richard Hindley
Gordon Muir
M. Emberton
Clare Allen
Abdel-Rahmène Azzouzi
Neil Barber
Eric Barret
Nimalan Arumainayagam
John Trachtenberg
Source :: European Urology Supplements. 9:294
Publication Year :: 2010
Publisher :: Elsevier BV, 2010.

Subjects :: Oncology
medicine.medical_specialty
Prostate cancer
business.industry
Padeliporfin
Urology
medicine.medical_treatment
Internal medicine
Medicine
Photodynamic therapy
business
medicine.disease

Full Text Access

Tools